Hubei Zhenhua Chemical Co.,Ltd. (SHA:603067)
China · Delayed Price · Currency is CNY 34.98
-0.57 (-1.60%)
Apr 30, 2026, 3:00 PM CST
Hubei Zhenhua Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,710 | 4,536 | 4,054 | 3,686 | 3,494 | 2,956 |
Other Revenue | - | - | 12.73 | 12.85 | 39.96 | 36.99 |
| 4,710 | 4,536 | 4,067 | 3,699 | 3,534 | 2,993 | |
Revenue Growth (YoY) | 13.81% | 11.53% | 9.95% | 4.67% | 18.06% | 134.13% |
Cost of Revenue | 3,439 | 3,315 | 3,054 | 2,802 | 2,588 | 2,252 |
Gross Profit | 1,271 | 1,221 | 1,012 | 896.32 | 945.58 | 740.81 |
Selling, General & Admin | 392.31 | 367.11 | 295.05 | 297.44 | 289.78 | 249.87 |
Research & Development | 138.56 | 147.34 | 128.35 | 114.61 | 106.32 | 82.74 |
Other Operating Expenses | 8.9 | 0.22 | 4.29 | 23.04 | 27.69 | 23.71 |
Operating Expenses | 539.78 | 514.66 | 432.77 | 435.62 | 424.21 | 354.43 |
Operating Income | 731.5 | 706.31 | 579.48 | 460.69 | 521.37 | 386.39 |
Interest Expense | - | - | -36.92 | -35.27 | -33.79 | -36.87 |
Interest & Investment Income | 0.79 | 4.8 | 3.68 | 5.05 | 5.58 | 4.05 |
Currency Exchange Gain (Loss) | - | - | 5.69 | 1.26 | 8.5 | -0.26 |
Other Non Operating Income (Expenses) | 76.88 | 84.82 | -1.99 | -0.83 | -0.84 | -11.49 |
EBT Excluding Unusual Items | 809.33 | 795.94 | 549.95 | 430.9 | 500.82 | 341.81 |
Impairment of Goodwill | - | - | - | -1.28 | - | - |
Gain (Loss) on Sale of Investments | -9.87 | -12.42 | -9.92 | -8.36 | -19.75 | -2.04 |
Gain (Loss) on Sale of Assets | -0.01 | 0.05 | -8.32 | -14.78 | -5.79 | -0.35 |
Asset Writedown | -42.81 | -40.27 | 0.3 | 0.02 | 0.06 | -5.16 |
Other Unusual Items | - | - | 9.01 | 8.02 | 8.15 | - |
Pretax Income | 756.64 | 743.3 | 541.02 | 414.52 | 483.49 | 334.26 |
Income Tax Expense | 94.98 | 86.85 | 69.28 | 42.16 | 59.8 | 22.43 |
Earnings From Continuing Operations | 661.66 | 656.45 | 471.74 | 372.36 | 423.69 | 311.83 |
Minority Interest in Earnings | 1.61 | 2.59 | 1.14 | -1.55 | -6.71 | -1.16 |
Net Income | 663.27 | 659.04 | 472.88 | 370.81 | 416.97 | 310.67 |
Net Income to Common | 663.27 | 659.04 | 472.88 | 370.81 | 416.97 | 310.67 |
Net Income Growth | 31.41% | 39.37% | 27.53% | -11.07% | 34.22% | 107.34% |
Shares Outstanding (Basic) | 715 | 709 | 704 | 701 | 703 | 690 |
Shares Outstanding (Diluted) | 747 | 740 | 720 | 711 | 712 | 690 |
Shares Change (YoY) | 3.22% | 2.90% | 1.19% | -0.10% | 3.12% | 15.19% |
EPS (Basic) | 0.93 | 0.93 | 0.67 | 0.53 | 0.59 | 0.45 |
EPS (Diluted) | 0.89 | 0.89 | 0.66 | 0.52 | 0.59 | 0.45 |
EPS Growth | 27.31% | 35.44% | 26.03% | -10.98% | 30.16% | 80.00% |
Free Cash Flow | -191.61 | -81.04 | 49.12 | 103.65 | 230.66 | 78.27 |
Free Cash Flow Per Share | -0.26 | -0.11 | 0.07 | 0.15 | 0.32 | 0.11 |
Dividend Per Share | - | - | 0.136 | 0.131 | 0.148 | 0.131 |
Dividend Growth | - | - | 3.83% | -11.63% | 12.56% | 100.00% |
Gross Margin | 26.99% | 26.92% | 24.89% | 24.23% | 26.76% | 24.75% |
Operating Margin | 15.53% | 15.57% | 14.25% | 12.46% | 14.75% | 12.91% |
Profit Margin | 14.08% | 14.53% | 11.63% | 10.03% | 11.80% | 10.38% |
Free Cash Flow Margin | -4.07% | -1.79% | 1.21% | 2.80% | 6.53% | 2.61% |
EBITDA | 984.85 | 950.02 | 784.6 | 655.29 | 709.8 | 551.17 |
EBITDA Margin | 20.91% | 20.95% | 19.29% | 17.72% | 20.09% | 18.41% |
D&A For EBITDA | 253.36 | 243.71 | 205.11 | 194.6 | 188.42 | 164.79 |
EBIT | 731.5 | 706.31 | 579.48 | 460.69 | 521.37 | 386.39 |
EBIT Margin | 15.53% | 15.57% | 14.25% | 12.46% | 14.75% | 12.91% |
Effective Tax Rate | 12.55% | 11.68% | 12.80% | 10.17% | 12.37% | 6.71% |
Revenue as Reported | - | - | 4,067 | 3,699 | 3,534 | - |
Advertising Expenses | - | - | 1.92 | 1.7 | 0.49 | 0.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.